# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-15-059190
Filing Date
2015-10-13
Accepted
2015-10-13 16:02:32
Documents
33
Period of Report
2015-10-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | v422110_8-k.htm | 8-K | 14199
2 | EXHIBIT 99.1 | v422110_ex99-1.htm | EX-99.1 | 30797
3 | GRAPHIC | ex99x1_001.jpg | GRAPHIC | 50297
4 | GRAPHIC | ex99x1_002.jpg | GRAPHIC | 115565
5 | GRAPHIC | ex99x1_003.jpg | GRAPHIC | 153166
6 | GRAPHIC | ex99x1_004.jpg | GRAPHIC | 117636
7 | GRAPHIC | ex99x1_005.jpg | GRAPHIC | 114301
8 | GRAPHIC | ex99x1_006.jpg | GRAPHIC | 90272
9 | GRAPHIC | ex99x1_007.jpg | GRAPHIC | 125852
10 | GRAPHIC | ex99x1_008.jpg | GRAPHIC | 83061
11 | GRAPHIC | ex99x1_009.jpg | GRAPHIC | 146682
12 | GRAPHIC | ex99x1_010.jpg | GRAPHIC | 83921
13 | GRAPHIC | ex99x1_011.jpg | GRAPHIC | 134476
14 | GRAPHIC | ex99x1_012.jpg | GRAPHIC | 82270
15 | GRAPHIC | ex99x1_013.jpg | GRAPHIC | 174989
16 | GRAPHIC | ex99x1_014.jpg | GRAPHIC | 127883
17 | GRAPHIC | ex99x1_015.jpg | GRAPHIC | 123189
18 | GRAPHIC | ex99x1_016.jpg | GRAPHIC | 155410
19 | GRAPHIC | ex99x1_017.jpg | GRAPHIC | 108617
20 | GRAPHIC | ex99x1_018.jpg | GRAPHIC | 103017
21 | GRAPHIC | ex99x1_019.jpg | GRAPHIC | 98042
22 | GRAPHIC | ex99x1_020.jpg | GRAPHIC | 117031
23 | GRAPHIC | ex99x1_021.jpg | GRAPHIC | 123917
24 | GRAPHIC | ex99x1_022.jpg | GRAPHIC | 100674
25 | GRAPHIC | ex99x1_023.jpg | GRAPHIC | 142442
26 | GRAPHIC | ex99x1_024.jpg | GRAPHIC | 119666
27 | GRAPHIC | ex99x1_025.jpg | GRAPHIC | 107805
28 | GRAPHIC | ex99x1_026.jpg | GRAPHIC | 159445
29 | GRAPHIC | ex99x1_027.jpg | GRAPHIC | 113779
30 | GRAPHIC | ex99x1_028.jpg | GRAPHIC | 102402
31 | GRAPHIC | ex99x1_029.jpg | GRAPHIC | 191113
32 | GRAPHIC | ex99x1_030.jpg | GRAPHIC | 115728
33 | GRAPHIC | image_001.jpg | GRAPHIC | 17889
| Complete submission text file | 0001144204-15-059190.txt |  | 5008244

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 151156139
SIC: 2834 Pharmaceutical Preparations